| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/01/2004 | EP1450750A2 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase |
| 09/01/2004 | EP1450666A2 Methods and compositions to treat cardiovascular disease using 139,258,1261,1486,2398,2414,7660,8587,10183,10550,12680,17921,32248,60489 or 93804 |
| 09/01/2004 | EP1450604A2 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation |
| 09/01/2004 | EP1274675B1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 09/01/2004 | EP1261349A4 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 09/01/2004 | EP1242410B1 Novel compounds |
| 09/01/2004 | EP1228024B1 Novel hydronaphthalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 09/01/2004 | EP1194138A4 Nutritional supplements |
| 09/01/2004 | EP1140851B1 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents |
| 09/01/2004 | EP1131037B1 Process for the manufacture of liquid filled capsules |
| 09/01/2004 | EP1127058B1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 09/01/2004 | EP1121064B1 Method and device for preparing a dental implant by immersion in a mesenchymal cell culture |
| 09/01/2004 | EP0984955B1 Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing tnf alpha levels |
| 09/01/2004 | EP0984771A4 Stabilized gas-supersaturated emulsions and suspensions |
| 09/01/2004 | EP0923530B1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
| 09/01/2004 | CN1526020A Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins. |
| 09/01/2004 | CN1526018A Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/01/2004 | CN1526017A Gene associated with leishmania parasite virulence |
| 09/01/2004 | CN1526011A Inhibition of apoptosis process and improvement of cell performance |
| 09/01/2004 | CN1525979A Bridged bicyclic serine protease inhibitors |
| 09/01/2004 | CN1525978A C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/01/2004 | CN1525974A Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 09/01/2004 | CN1525972A Hetero-bicyclic crf antagonists |
| 09/01/2004 | CN1525967A N-苯基-2-嘧啶胺衍生物 N- phenyl-2-pyrimidine-amine derivatives |
| 09/01/2004 | CN1525966A New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias |
| 09/01/2004 | CN1525962A De Rock Herman Augustinus |
| 09/01/2004 | CN1525957A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 09/01/2004 | CN1525956A Alpha -amino-n-hydroxy-acetamide derivatives |
| 09/01/2004 | CN1525955A Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 09/01/2004 | CN1525954A Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 09/01/2004 | CN1525868A Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 09/01/2004 | CN1525865A Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 09/01/2004 | CN1525859A Use of cyclopamine in the treatment of basal cell carcinoma and other tumors |
| 09/01/2004 | CN1525857A Method for regulation of gene expression in eukaryotic cells using nordihydroguaiaretic acid derivatives |
| 09/01/2004 | CN1525818A Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation |
| 09/01/2004 | CN1164591C Hydrated forms of zilpatherol hydrochloride |
| 09/01/2004 | CN1164579C Thiazole and oxazole derivatives and their pharmaceutical use |
| 09/01/2004 | CN1164574C Phenoxypropylamine compounds |
| 09/01/2004 | CN1164317C Revival pill for treating woman diseases |
| 09/01/2004 | CN1164310C Medicinal powder for domestic animals to invigorate kidney and become plump |
| 09/01/2004 | CN1164301C Pseudo-ginseng instant powder and its preparation method |
| 09/01/2004 | CN1164298C Chinese medicine for treating cold and cough and its preparation method |
| 09/01/2004 | CN1164284C Medicine powder for treating neonatal jaundice |
| 09/01/2004 | CN1164277C Coma treating medicine composition |
| 09/01/2004 | CN1164270C Application of safrole oxide in the growth and death of vascular endothelial cell |
| 09/01/2004 | CN1164266C Special inhibitor for ruminant urease |
| 08/31/2004 | US6784298 2-((3-cyclohexyl-2-(2,5-dioxo-4-(thiophen-2-yl)methylimida-zol idin-1-yl)propanoyl)amino) thiazole-4-carboxylic acid methyl ester, e.g.; antidiabetic agents; hypoglycemic agents; a glucose sensor in beta-cells and hepatocytes |
| 08/31/2004 | US6784291 Splice-region antisense composition and method |
| 08/31/2004 | US6784210 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
| 08/31/2004 | US6784205 Compounds that modulate the activity of PTP-1B and TC-PTP |
| 08/31/2004 | US6784195 Extracellular signal regulated kinase (erk); anticancer agents and protein kinase inhibitors |
| 08/31/2004 | US6784188 Urea substituted imidazoquinolines |
| 08/31/2004 | US6784187 8-carboxamido-2,6-methano-3-benzazocines |
| 08/31/2004 | US6784181 Ligands for the delta receptor |
| 08/31/2004 | US6784179 Tetracyclic derivatives, process of preparation and use |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/31/2004 | US6784173 Aromatic dicarboxylic acid derivatives |
| 08/31/2004 | US6784169 Metalloprotease inhibitor; antiinflamamtory agents; rheumatic disorders; cardiovascular disorders; controlling cell proliferation |
| 08/31/2004 | US6784161 Method for the treatment or prevention of flavivirus infections using nucleoside analogues |
| 08/31/2004 | US6784157 Peptide activates dna binding of wild-type p53 or a p53 mutant containing a single amino acid substitution; a peptidomimetic consisting of four sequential amino acids from a negative regulatory region; anticarcinogenic, -tumor agents |
| 08/31/2004 | US6784155 Contacting hematopoietic cells with a stem cell proliferation stimulating amount of inprol or an opiate compound or a combination of inprol and an opiate compound |
| 08/31/2004 | US6784153 Identify molecules that can bind to organ or tissue specific markers and, therefore, can home to the organ or tissue; membrane dipeptidase (mdp)-binding homing molecule, which is a molecule that selectively homes to lung endothelium |
| 08/31/2004 | US6783977 Internal ribosome entry site and vector containing same |
| 08/31/2004 | US6783955 Polynucleotides encoding human presenilin variant |
| 08/31/2004 | US6783949 Reacting fluorescently labeled fatty acid with 2,3-epoxypropanol to form monoglyceride which is subjected to ultrasonic treatment with phospholipids; drug screening; for detecting metabolic disorders |
| 08/31/2004 | US6783935 Genetic polymorphism of MxA protein and use thereof |
| 08/31/2004 | US6783775 Comprising ceruloplasmin and a serum-derived composition (sdf) having a low molecular weight, electrically charged at acidic ph and having absorption at 280 mn, capable of inducing terminal cell differentiation of leukemic cells |
| 08/31/2004 | US6783761 Hormone inhibitors for inducing antibodies against gonadotropin-releasing hormone, comprises fusion peptide of helper t-cell peptide epitope and immunomimic peptide epitope |
| 08/31/2004 | US6783753 Rapidly produces peak plasma concentrations of the compound. |
| 08/31/2004 | CA2098076C Imidate prodrugs of pharmaceutically useful anticonvulsant sulfamates |
| 08/26/2004 | WO2004072056A1 Medicinal composition |
| 08/26/2004 | WO2004072018A1 Amine derivative |
| 08/26/2004 | WO2004071520A1 Bifidobacterium preparation for improving immune functions |
| 08/26/2004 | WO2004071516A1 Glycyrrhizine-containing percutaneous preparation |
| 08/26/2004 | WO2004071509A1 Oligodendrocyte differentiation promoters |
| 08/26/2004 | WO2004071481A1 Melanogenesis inhibitor and skin preparation containing the same |
| 08/26/2004 | WO2004018684A3 T-cell epitopes in staphylococcal enterotoxin b |
| 08/26/2004 | WO2004013310A3 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 08/26/2004 | WO2004006831A3 Method and device for inducing biological processes by micro-organs |
| 08/26/2004 | WO2003092602A3 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 08/26/2004 | WO2003090681A3 SYNERGISTIC EFFECTS OF NUCLEAR TRANSCRIPTION FACTOR NF-κB INHIBITORS AND ANTI-NEOPLASTIC AGENTS |
| 08/26/2004 | WO2003070911A3 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r) |
| 08/26/2004 | WO2002102320A3 Fce fusion proteins for treatment of allergy and asthma |
| 08/26/2004 | WO2001051003A3 Use of lipid conjugates in the treatment of disease |
| 08/26/2004 | US20040167352 Clarifying by centrifugation or filtration; adsorption on nonionic resin; adsorption efficiency greatly increased in strong basicity of ph 10 to 13 |
| 08/26/2004 | US20040167341 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 08/26/2004 | US20040167337 Boron compounds such as R)-1-{(S)-2-[(S)-2-(biphenyl-3-ylamino)-(3-(3,4,5-trimethoxy-phenyl)-propionylamino]-3-methyl-butyrylamino}-3-methyl-butylboronic acid, used as antitumor or antiproliferative agents |
| 08/26/2004 | US20040167336 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine |
| 08/26/2004 | US20040167332 Boronic ester and acid compounds, synthesis and uses |
| 08/26/2004 | US20040167228 aerosols containing atenolol, pindolol, esmolol, propranolol, or metoprolol that are used in inhalation therapy |
| 08/26/2004 | US20040167224 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 08/26/2004 | US20040167201 Pyrrolidine melanocortin-specific compounds |
| 08/26/2004 | US20040167183 Protein tyrosine phosphatase inhibitor; antidiabetic agents; hypotensive agents; cardiovascular disorders; inflammatory bowel disorders; antiulcer agents; wound healing agents; anticancer agents |
| 08/26/2004 | US20040167176 Tricyclic compounds useful as angiotensin II agonists |
| 08/26/2004 | US20040167174 Substituted acylhydroxamic acids and method of reducing TNFalpha levels |
| 08/26/2004 | US20040167171 Prevention, therapy of neurodegenerative disease; diffusion through brain, blood barrier; Alzheimer's, Parkinson's Huntington's diseases, Amyotrophic lateral sclerosis |
| 08/26/2004 | US20040167169 Antihistamines, antiallergens; bronchodilator |
| 08/26/2004 | US20040167160 Skin disorders; controlling cell differentiation; antidiabetic agents; cardiovascular disorders; anticancer agents; central nervous system disorders |
| 08/26/2004 | US20040167158 Heterocyclic compounds for the treatment of migraine |
| 08/26/2004 | US20040167154 Urea substituted imidazoquinolines |